Ketogenic Diet for Nephropathic Cystinosis

Nephropathic cystinosis is rare genetic disorder, characterized by the accumulation of cystine within lysosomes, leads to renal Fanconi syndrome and eventual kidney failure. The current standard treatment with cysteamine has been effective in extending patient lifespan, yet it is associated with various side effects that can impair quality of life. The recent pre-clinical studies showing the benefits of a ketogenic diet in animal models present a potential alternative that may alleviate renal symptoms and improve patient outcomes. The diet's impact on reducing kidney damage, such as fibrosis and inflammation, and preserving tubular function, even after the onset of dysfunction, is particularly noteworthy. These findings suggest that the ketogenic diet could be a viable option for managing the renal complications of nephropathic cystinosis, and further research in human clinical trials could pave the way for new dietary guidelines in the treatment protocol for this condition. It is an encouraging development that offers hope for patients and families affected by this challenging disease.